
|Videos|October 11, 2016
Atopic Dermatitis: Cost and Value
Advertisement
Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Jonathan Silverberg, MD, PhD, MPH; Ed Pezalla, MD, MPH; and Jeffrey D. Dunn, PharmD, MBA, provide insight on balancing the cost and benefit of treatments for atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Understanding Myelofibrosis and the Central Role of JAK Pathway Dysregulation
3
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
4
Pharmacists’ Expanding Role in Optimizing Oral Endocrine and Targeted Breast Cancer Therapies
5




































































































































































































